IPO Pipeline Update – Week Ending 5.4.18

IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of May 4, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.

Screen Shot 2018-05-04 at 7.28.33 PM

NEW FILINGS

NEW FILINGS
Company: Scholar Rock Holding Corporation
Symbol: SRRK
Description: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Jefferies, Cowen, BMO Capital
Co-Manager(s): Wedbush PacGrow
Filed: 4-27-18
Listed Cash Raise: $75m

Company: Kiniksa Pharmaceuticals, Ltd.
Symbol: KNSA
Description: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan
Co-Manager(s): JMP Securities, Wedbush PacGrow
Filed: 4-27-18
Listed Cash Raise: $100m

Company: GreenSky, Inc.
Symbol: GKSY
Description: They are a leading technology company that powers commerce at the point of sale.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphrey
Co-Manager(s): Raymond James, Sandler O’ Neill, Fifth Third Securities, Guggenheim Securities
Filed: 4-27-18
Listed Cash Raise: $100m

Company: Iterum Therapeutics plc
Symbol: ITRM
Description: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Leerink Partners, RBC Capital Partners
Co-Manager(s): Guggenheim Securities, Needham & Co.
Filed: 5-1-18
Listed Cash Raise: $92m

Company: DERMADoctor, Inc.
Symbol: DDOC
Description: They are an omni-channel, innovative, skincare company primarily focused on the creation of products that are designed to target common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris.
Trade Date: TBD
Shares: 1.875 million
Price Range: $7.00-$9.00
Underwriter(s): ThinkEquity
Filed: 5-2-18
Listed Cash Raise: $17.25m

TERMS ADDED

Company: Evelo Biosciences, Inc.
Symbol: EVLO
Description: Evelo Biosciences is discovering and developing potential therapies designed to act on the gut-body network.
Trade Date: 5/9
Shares: 5.3 million
Price Range: $15.00-$17.00
Underwriter(s): Morgan Stanley, Cowen, BMO Capital Markets
Co-Manager(s): JMP Securities
Terms Added: 4-30-18

Company: HUYA, Inc.
Symbol: HUYA
Description: They are the No.1 game live streaming platform in China.
Trade Date: 5/11
Shares: 15 million ADS
Price Range: $10.00-$12.00
Underwriter(s): Credit Suisse, Goldman Sachs (Asia), UBS Investment Bank
Co-Manager(s): Needham & Co.
Terms Added: 5-1-18

Company: Abpro Corporation
Symbol: ABP
Description: They are a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases.
Trade Date: 5/11
Shares: 4 million
Price Range: $14.00-$16.00
Underwriter(s): UBS Investment Bank, Wells Fargo Securities, Nomura, Oppenheimer & Co.
Terms Added: 5-2-18

IPO Pipeline Update – Week Ending 5.4.18
Scroll to top
error: Content is protected !!